JOSEPH (JAY) ZWISCHENBERGER, M.D.
CHIEF MEDICAL OFFICER, CARDIOTHORACIC SURGEON, CRITICAL CARE
Dr. Zwischenberger serves at the University of Kentucky as Professor of Surgery
Roger is a Certified Clinical Perfusionist Emeritus, and he received his Ph.D. from the University of Texas in Biomedical Sciences with a concentration in Experimental Oncologic Pathology.
JAN WINETZ, M.D.
CHIEF CLINICAL OFFICER
Jan is Board Certified in Internal Medicine and Nephrology. Jan graduated from the
Cornell University Medical College, residency and served as a Chief Resident at S.U.N.Y.
LOU LANG
BOARD MEMBER, CONSULTANT
MAREK STUBLEY
BOARD MEMBER, CONSULTANT
ROGER VERTREES, PH.D.
CHAIRMAN OF THE BOARD, CHIEF SCIENCE & TECHNOLOGY OFFICER
Roger is a Certified Clinical Perfusionist Emeritus, and he received his Ph.D. from the
University of Texas in Biomedical Sciences with a concentration in Experimental
Oncologic Pathology.
JAY SMITH
BOARD MEMBER, SECRETARY
Jay was a certified public accountant with a large national firm and has over 30 years of
experience as a financial executive.
GARY KEELING
BOARD MEMBER
Gary has been active in the hyperthermia sector since 1992 and received the first FDA
IDE to treat AIDS patients with whole-body hyperthermia in 1995.
PETRA SMELTZER STARKE
BOARD MEMBER
Petra Smelter Starke is the founder and CEO of a global growing hot yoga healthy
lifestyle brand SweatNGlow.
RAY STAPLETON
BOARD MEMBER
T. Ray Stapleton is the former Chief Budget Officer of the world’s most preiment
International Labor Organization
JAN WINETZ, M.D.
CHIEF CLINICAL OFFICER
DENNIS CHI, M.D
ONCOLOGIST
Dr. Chi has been an attending surgeon at Memorial Sloan Kettering Cancer Center for
more than 25 years.
JAMES CUSACK, M.D
GASTROINTESTINAL SURGEON, COLORECTAL SURGEON
Dr. Cusack serves on the Harvard Medical School faculty, Massachusetts General staff,
and the consulting staff at Dana-Farber Cancer Institute.
ROBERT DEBERNARDO, M.D.
ASSOCIATE PROFESSOR, ONCOLOGY SPECIALIST
Dr. DeBernardo is a Cleveland Clinic Gynecologic Oncologist and is also the Director of
Minimally Invasive Surgery in Cleveland Clinic’s Ob/Gyn & Women’s Health Institute
DANIEL LABOW, M.D.
SURGICAL ONCOLOGIST
Dr. Labow is the Executive Vice Chair of the Department of Surgery at Mount Sinai. He i
additionally the Vice Chair of Quality for the Department of Surgery
JOSEPH ZWISCHENBERGER, M.D.
Dr. Zwischenberger serves at the University of Kentucky, Professor of Surgery and
Pediatrics,
DAVID BARTLETT, M.D.
CHAIR OF THE AHN CANCER INSTITUTE, ALLEGHENY HEALTH NETWORK
Dr. Bartlett is the Chair of the Allegheny Health Network Cancer Institute. Prior to that, he
served as the Vice Chairman of Surgical Oncology
Our ovarian cancer trial resulted in significant findings on the positive impacts of HEATT®. Patients overall experienced improved survival rates and daily living satisfaction.
Verthermia® trial patients with unresponsive lung cancer exceeded average life expectancy after receiving HEATT®.
Dr. Zwischenberger serves at the University of Kentucky as Professor of Surgery,
Pediatrics, interventional radiology, and bioengineering. He is the former Chair of the
Department of Surgery and Surgeon-in-Chief of UK Healthcare. He has been involved in
continuous research since 1987 with over 60 funded projects focused on severe
respiratory failure, lung cancer, and artificial lung development. He has served on
several NIH studies as review and chairman, and has over 400 peer-reviewed
publications. He has an extensive background in Extracorporeal Membrane Oxygenation
(CMO) and Venovenous Perfusion-Induced Systemic Hyperthermia.
Roger received his Ph.D. from the University of Texas in Biomedical Sciences. with a
concentration in Experimental Oncologic Pathology. A Board-Certified Cardiovascular
Perfusionist, Roger has applied this clinical expertise to over 30 years of research in
whole-body
Jan is Board Certified in Internal Medicine and Nephrology. Jan graduated from the
Cornell University Medical College, residency and served as a Chief Resident at S.U.N.Y.
Jan also served a fellowship at Stanford University Medical Center where he won two
National Kidney Foundation Fellowships for his research. Jan has multiple peer reviewed
publications. A practicing Nephrologist for over 30 years, Jan was instrumental in the
Company’s recent Phase 1 Ovarian Hyperthermia trials.
Mitchel has over 30 years of experience in complex financial transactions, investing, and
operational management. He has been involved in the formation and management of
over 15 successful businesses through his corporate consulting. Mitchel has assisted his
high-net-worth clients with structuring deals and has been the principal investor in
several successful ventures. Mitchel was instrumental in start-up businesses in health
care and sports publications. Mitchel holds a JD from Fordham University School of Law
as well as a Bachelor of Administration from Clark University. Mitchel started his career
practicing law in New York City and is an admitted member of the State Courts of New
York and The Bar Association of New York as well as the American Bar Association.
Petra Smeltzer Starke is the founder and CEO of a global growing hot yoga healthy
lifestyle brand SweatNGlow. She partners nationwide with businesses and charities to
promote yoga, fitness, skincare, and nutrition. She is the author of a bestselling book on
her journey from Communism growing up in Czechoslovakia to her times in the Obama
White House. Her book highlights how Yoga was her means of mental and physical
support. Previously, Petra graduated at the top of her class from Georgetown Law
before practicing law at the firm of O’Melveny & Meyers, LLP. At the firm, she represented
political nominees and appointees during the Bush Administration. She was subsequently
recruited for the Obama Presidential Transition. Later she worked in the Obama White
House where she served as General Counsel to the White House Council of Economic
Advisors and Senior Advisor to the President. More recently she served as a member of
the Biden-Harris Transition Team.
Jay was a certified public accountant with a large national firm and has over 30
years of experience as a financial executive. Jay has successfully established and
managed businesses in manufacturing, distribution, importing, and agriculture. Jay
initially joined the company as the interim CFO and helped support capital raising
efforts. Jay holds a BS and an MBA from the University of Southern California.
Jan is Board Certified in Internal Medicine and Nephrology. Jan graduated from the
Cornell University Medical College with a residency, and then he served as a Chief
Resident at S.U.N.Y. affiliated hospitals at Buffalo, N.Y. Jan also served a fellowship at
Stanford University Medical Center where he won two National Kidney Foundation
Fellowships for his research. Jan has multiple peer-reviewed publications and has
been a practicing Nephrologist for over 30 years. Jan was instrumental in the
company’s Phase 1 ovarian hyperthermia trials.
Dr. Chi has been an attending surgeon at Memorial Sloan Kettering Cancer Center
for more than 25 years. Since 2010, he has served as Deputy Chief of the
Gynecology Service, and he has been Head of the Ovarian Cancer Surgery Section
since 2014. Dr. Chi specializes in gynecologic oncology for cervical cancer, uterine
cancer, and ovarian cancer. He additionally has extensive experience in minimally
invasive cancer techniques.
Dr. Cusack serves on the Harvard Medical School faculty, Massachusetts General
staff, and the consulting staff at Dana-Farber Cancer Institute. At Massachusetts
General, Dr. Cusack is the Director of the Peritoneal Surface Malignancy (HIPEC)
Program and Surgical Oncology Laboratories. He was additionally Chair of the SSO
Scientific Program Committee and served on the Executive Council of the Society of
Surgical Oncology (SSO).